Beleave Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Beleave Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Beleave's Price has grown, moving from $0.00 to $0.00 – an increase of 100.00%. In the next year, analysts predict that Fair Value will jump to $0.00 – up 100.00% from the current level. Looking ahead to six years, experts forecast that Fair Value will grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
TLRY Stock Forecast | Tilray, Inc. prior to merger w... | - |
6
|
$18.34 | Buy/Sell | $22.00 | -100.00% |
TLRY Stock Forecast | Tilray Brands | Outperform |
6
|
$2.47 | Buy/Sell | $2.74 | -10.93% |
SNDL Stock Forecast | SNDL | Buy |
7
|
$2.47 | Buy/Sell | $4.96 | 99.19% |
ACB Stock Forecast | Aurora Cannabis | Outperform |
6
|
C$12.65 | Buy/Sell | C$1.06 | -36.76% |
WEED Stock Forecast | Canopy Growth | Hold |
7
|
C$20.45 | Buy/Sell | C$0.94 | -70.66% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
OGI Stock Forecast | Organigram Holdings | Outperform |
5
|
C$2.92 | Buy/Sell | C$3.31 | 28.42% |
DB Stock Forecast | Decibel Cannabis | Buy |
0
|
C$0.13 | Buy/Sell | C$0.50 | 169.23% |
HUGE Stock Forecast | FSD Pharma | - |
4
|
C$0.57 | Buy/Sell | C$15.45 | -100.00% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BZAM Stock Forecast | BZAM | - |
0
|
C$0.03 | Buy/Sell | C$2.00 | -100.00% |
ENTG Stock Forecast | Entourage Health | - |
0
|
C$0.02 | Buy/Sell | C$0.05 | -100.00% |
DN Stock Forecast | Delta 9 Cannabis | Hold |
0
|
C$0.03 | Buy/Sell | C$0.06 | 100.00% |
Beleave EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Beleave's EPS has grown, moving from $0.00 to $0.00 – an increase of 100.00%. In the next year, analysts predict that EPS will jump to $0.00 – up 100.00% from the current level. Looking ahead to six years, experts forecast that EPS will grow by 100.00%.